Mission acomplia- the goal is a healthier world

When Acomplia, the wonder weight loss drug, hits the market, it will have a gigantic mission to complete - the mission to cure obesity in a 200 million strong population around the world. The mission at hand of Acomplia is a Herculean task in real. Not only because of the large number of people who require treatment but also because most of these people consider acomplia as the last resort.

Acomplia thus has the faith of many people to free them of the excess weight. Losing weight for many people is not just a task to become prettier or more handsome; it is a way to do away with the various health problems that have afflicted them because of being overweight. Diabetes, heart diseases, high blood pressure are some of the most common disorders that ensue because of being overweight.

Acomplia is well equipped for this mission, i. e. in dealing with excess weight. This drug works by blocking a pleasure center in the brain (known as Cannabinoid type I or CB1). Blocking CB1 receptors generate a feeling of satiety in the patients. Thus, patient automatically loses weight when food intake is reduced. This is the first in the kind of drugs with such mode of action.

Ours is a culture that believes in force feeding. Even if you are not hungry, you will surely consume something during mealtimes. Many people complained of a guilty feeling when they skipped meals. But what needs to be understood is that after 40 food is no longer required to promote growth and just to maintain oneself. With acomplia dampening appetite, a person will just consume sufficient and abstain from overeating, i. e. half the mission against obesity is accomplished.

Acomplia diet pill not only suppresses appetite but also has positive effects on the urge to smoke (although clinical trials on the drugs actual potential in this area have not yet been checked). Similarly, this drug improves cholesterol and blood sugar levels.

Patients who underwent tests during the research period reported a weight loss of an average 19 pounds and waist measure decreased by 3 inches after taking the drug for 2 years. The results are remarkable, if seen in comparison with patients who took a placebo. The latter were just able to lose 5 pounds and 1.5 inches from their waist.

Acomplia surely is not the first drug to combat the problem of obesity. Many drugs such as Fen-phen, which is a combination of Fenfluramine and Phentermine, too created much enthusiasm in users; but had to be withdrawn from the market after reports of heart valve problems. Similarly Meridia and Orlistat failed because of their severe side effects. Acomplia is not free of side effects either. But the side effects are milder. Nausea, mood alterations with depressive symptoms, anxiety and dizziness are some of the common side effects faced by users. Since acomplia is a prescription drug, the patient must have been recommended use of the drug by a certified doctor.